These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2977396)

  • 1. The clinical relevance of tumor marker CEA, CA 19-9 in regional chemotherapy of hepatic metastases of colorectal carcinoma.
    Safi F; Roscher R; Bittner R; Beger HG
    Int J Biol Markers; 1988; 3(2):101-6. PubMed ID: 2977396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?
    Bakalakos EA; Burak WE; Young DC; Martin EW
    Am J Surg; 1999 Jan; 177(1):2-6. PubMed ID: 10037299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy). Results of a controlled clinical trial.
    Safi F; Bittner R; Roscher R; Schuhmacher K; Gaus W; Beger GH
    Cancer; 1989 Jul; 64(2):379-87. PubMed ID: 2525415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal carcinoma liver metastases: clinical significance of preoperative measurement of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels.
    Ishizuka D; Shirai Y; Sakai Y; Hatakeyama K
    Int J Colorectal Dis; 2001 Feb; 16(1):32-7. PubMed ID: 11317695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancer.
    Ward U; Primrose JN; Finan PJ; Perren TJ; Selby P; Purves DA; Cooper EH
    Br J Cancer; 1993 May; 67(5):1132-5. PubMed ID: 8494712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic irinotecan or regional floxuridine chemotherapy prolongs survival after hepatic cryosurgery in patients with metastatic colon cancer refractory to 5-fluorouracil.
    Bilchik AJ; Wood TF; Chawla SP; Rose DM; Chung MH; Stern SS; Foshag LJ; Ramming KP
    Clin Colorectal Cancer; 2001 May; 1(1):36-42. PubMed ID: 12445377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of serial carcinoembryonic antigen: determinations to monitor the therapeutic progress and prognosis of metastatic liver disease treated by regional chemotherapy.
    Quentmeier A; Schlag P; Hohenberger P; Schwarz V; Abel U
    J Surg Oncol; 1989 Feb; 40(2):112-8. PubMed ID: 2915539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor marker evolution: comparison with imaging for assessment of response to chemotherapy in patients with colorectal liver metastases.
    de Haas RJ; Wicherts DA; Flores E; Ducreux M; Lévi F; Paule B; Azoulay D; Castaing D; Lemoine A; Adam R
    Ann Surg Oncol; 2010 Apr; 17(4):1010-23. PubMed ID: 20052553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Importance of Determining Preoperative Serum Concentration of Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen in Assessing the Progression of Colorectal Cancer.
    Halilovic E; Rasic I; Sofic A; Mujic A; Rovcanin A; Hodzic E; Kulovic E
    Med Arch; 2020 Oct; 74(5):346-349. PubMed ID: 33424087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic arterial infusion with floxuridine and cisplatin: overriding importance of antitumor effect versus degree of tumor burden as determinants of survival among patients with colorectal cancer.
    Patt YZ; Boddie AW; Charnsangavej C; Ajani JA; Wallace S; Soski M; Claghorn L; Mavligit GM
    J Clin Oncol; 1986 Sep; 4(9):1356-64. PubMed ID: 2943876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous intrahepatic infusion of floxuridine and leucovorin through an implantable pump for the treatment of hepatic metastases from colorectal carcinoma.
    Kemeny N; Cohen A; Bertino JR; Sigurdson ER; Botet J; Oderman P
    Cancer; 1990 Jun; 65(11):2446-50. PubMed ID: 2140070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The value of tumor markers in colorectal cancer].
    Peters KM; Grundmann R
    Leber Magen Darm; 1989 Jan; 19(1):18-25. PubMed ID: 2927234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumor markers in liver metastases of colorectal carcinoma].
    Moreno Sierra J; Vincent E; Gea M; Ortega MD; Borque M; Madrigal J; Pimentel C; Represa J
    Rev Esp Enferm Dig; 1990 Sep; 78(3):139-44. PubMed ID: 1980590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can biliary carcinoembryonic antigen identify colorectal cancer patients with occult hepatic metastases?
    Li Destri G; Lanteri R; Santangelo M; Torrisi B; Di Cataldo A; Puleo S
    World J Surg; 2006 Aug; 30(8):1494-9. PubMed ID: 16847713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour markers in colorectal cancer.
    Roberts PJ
    Scand J Gastroenterol Suppl; 1988; 149():50-8. PubMed ID: 3201159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAG-72 (CA 72-4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer.
    Guadagni F; Roselli M; Cosimelli M; Mannella E; Tedesco M; Cavaliere F; Grassi A; Abbolito MR; Greiner JW; Schlom J
    Cancer; 1993 Oct; 72(7):2098-106. PubMed ID: 8374868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of occult liver metastases in colorectal cancer by measurement of biliary carcinoembryonic antigen.
    Novell F; Trias M; Molina R; Filella X
    Anticancer Res; 1997; 17(4A):2743-6. PubMed ID: 9252708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of a combination assay of CEA, CA-19-9 and TPA in patients with colorectal cancer].
    Nishida O; Shiroto H; Satoh N; Nakajima Y; Manabe K; Kondoh Y; Sano F; Uchino J
    Gan No Rinsho; 1988 Aug; 34(9):1096-100. PubMed ID: 3172515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of CEA determination in follow-up of patients with liver metastasis of colorectal cancers with loco-regional chemotherapy].
    Schimpfle B; Matthias M; Wolff H; Mai C; Lüning M
    Zentralbl Chir; 1991; 116(1):45-50. PubMed ID: 2038900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor markers and assessment of response to intrahepatic chemotherapy of colon carcinoma.
    Sears HF; Shen JW; Herlyn M; Atkinson B; Engstrom PF; Koprowski H
    Am J Clin Oncol; 1985 Apr; 8(2):108-17. PubMed ID: 2939709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.